In its Silver Jubilee year, Amersham launched the world's first commercial RIA (radioimmunoassay) kit, for measuring the insulin level in the blood of diabetics. This precise and sensitive technique became a universal assay tool, particularly in clinical endocrinology, and Amersham led the scientific and commercial development.